Regulatory needs and activities to address the retinoid system in the context of endocrine disruption: The European viewpoint

por Grignard, Elise, Håkansson, Helen, Munn, Sharon
Publicado 2020

Adverse outcome pathway development from protein alkylation to liver fibrosis

por Horvat, Tomislav, Landesmann, Brigitte, Lostia, Alfonso, Vinken, Mathieu, Munn, Sharon, Whelan, Maurice
Publicado 2016

Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods

por Bal-Price, Anna, Pistollato, Francesca, Sachana, Magdalini, Bopp, Stephanie K., Munn, Sharon, Worth, Andrew
Publicado 2018

Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies

por Pistollato, Francesca, Madia, Federica, Corvi, Raffaella, Munn, Sharon, Grignard, Elise, Paini, Alicia, Worth, Andrew, Bal-Price, Anna, Prieto, Pilar, Casati, Silvia, Berggren, Elisabet, Bopp, Stephanie K, Zuang, Valérie
Publicado 2021

Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009

por Andersson, Niklas, Arena, Maria, Auteri, Domenica, Barmaz, Stefania, Grignard, Elise, Kienzler, Aude, Lepper, Peter, Lostia, Alfonso Maria, Munn, Sharon, Parra Morte, Juan Manuel, Pellizzato, Francesca, Tarazona, Jose, Terron, Andrea, Van der Linden, Sander
Publicado 2018

Chemical Safety Assessment Using Read-Across: Assessing the Use of Novel Testing Methods to Strengthen the Evidence Base for Decision Making

por Berggren, Elisabet, Amcoff, Patric, Benigni, Romualdo, Blackburn, Karen, Carney, Edward, Cronin, Mark, Deluyker, Hubert, Gautier, Francoise, Judson, Richard S., Kass, Georges E.N., Keller, Detlef, Knight, Derek, Lilienblum, Werner, Mahony, Catherine, Rusyn, Ivan, Schultz, Terry, Schwarz, Michael, Schüürmann, Gerrit, White, Andrew, Burton, Julien, Lostia, Alfonso M., Munn, Sharon, Worth, Andrew
Publicado 2015